中华临床医师杂志(电子版)
中華臨床醫師雜誌(電子版)
중화림상의사잡지(전자판)
CHINESE JOURNAL OF CLINICIANS(ELECTRONIC VERSION)
2014年
1期
150-154
,共5页
肺肿瘤%血管内皮生长因子A%受体,血管内皮生长因子%脱氧葡萄糖F18
肺腫瘤%血管內皮生長因子A%受體,血管內皮生長因子%脫氧葡萄糖F18
폐종류%혈관내피생장인자A%수체,혈관내피생장인자%탈양포도당F18
Lung neoplasms%Vascular endothelial growth factor A%Receptors,Vascular endothelial growth factor%Fluorodeoxyglucose F18
肺癌是恶性肿瘤致死的首位死因,局部复发及转移是其主要原因。血管内皮因子具有刺激新生血管的作用,与肺癌肿瘤血管的生成及转移有关。近年来,PET 在肺癌的诊断、分期、判断复发及疗效等方面有独到的作用。本文旨在简要综述血管内皮生长因子(VEGF)及其受体(VEGFR)的生物学行为以及VEGF结合PET检查在肺癌诊治方面的临床价值,以期提高肺癌的临床诊治水平。
肺癌是噁性腫瘤緻死的首位死因,跼部複髮及轉移是其主要原因。血管內皮因子具有刺激新生血管的作用,與肺癌腫瘤血管的生成及轉移有關。近年來,PET 在肺癌的診斷、分期、判斷複髮及療效等方麵有獨到的作用。本文旨在簡要綜述血管內皮生長因子(VEGF)及其受體(VEGFR)的生物學行為以及VEGF結閤PET檢查在肺癌診治方麵的臨床價值,以期提高肺癌的臨床診治水平。
폐암시악성종류치사적수위사인,국부복발급전이시기주요원인。혈관내피인자구유자격신생혈관적작용,여폐암종류혈관적생성급전이유관。근년래,PET 재폐암적진단、분기、판단복발급료효등방면유독도적작용。본문지재간요종술혈관내피생장인자(VEGF)급기수체(VEGFR)적생물학행위이급VEGF결합PET검사재폐암진치방면적림상개치,이기제고폐암적림상진치수평。
Lung cancer is the leading cause of death by cancer, and local recurrence and metastasis are the most important factors. The vascular endothelial growth factor (VEGF) can promote angiogenesis, which is positive related to tumor angiogenesis and metastasis. In recent years, positron emission tomography (PET) plays an important role in diagnosis, staging, recurrence and prognosis of lung cancer. This paper briefly reviewed the biological behaviors of VEGF and VEGFR, and the clinical value of VEGF combines with PET imaging for lung cancer. It is expected to promote the diagnosis and therapy of lung cancer to further level.